Understanding the TXA seizure connection
Name
Brown_Understanding the TXA.pdf
Size
181.74 KB
Format
Adobe PDF
Checksum (MD5)
136b14e5cc22b5b5f4f46a8da26137a7
Author(s)
Schwinn, Debra A.
Mackensen, G. Burkhard
Brown, Emery N.
Date Issued
November 2012
Journal
Journal of Clinical Investigation
Publisher
American Society for Clinical Investigation
Citation
Schwinn, Debra A., G. Burkhard Mackensen, and Emery N. Brown. “Understanding the TXA Seizure Connection.” J. Clin. Invest. 122, no. 12 (December 3, 2012): 4339–4341. © 2012 American Society for Clinical Investigation
Version
Final published version
Abstract
Transexamic acid (TXA) is an antifibrinolytic that has been used successfully to prevent blood loss during major surgery. However, as its usage has increased, there have been growing reports of postsurgical seizure events in cardiac surgery patients. In this issue of the JCI, Lecker et al. explore this connection and suggest that TXA-mediated inhibition of glycine receptors may underlie the effect. This finding prompted the authors to explore the preclinical efficacy of common anesthetics that function by reducing the TXA-mediated inhibition to prevent or modify postsurgical seizures.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1172/jci66724
